Recent investigation revealed that elevated expression levels of the substrate-binding protein suppressor of cytokine signaling 3 (SOCS3) in the CRL5 complex are correlated with chemo- and radioresistance in GBM [12,13,14]. The gene discussed is SOCS3; the disease is glioblastoma.